CEFACLOR - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefaclor and what is the scope of freedom to operate?
Cefaclor
is the generic ingredient in four branded drugs marketed by Lilly, Ceph Intl, Chartwell Rx, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Yung Shin Pharm, Facta Farma, Watson Labs Inc, Ranbaxy Labs Ltd, and World Gen, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for cefaclor. Four suppliers are listed for this compound.
Summary for CEFACLOR
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 13 |
NDAs: | 33 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 4 |
Patent Applications: | 7,182 |
Drug Prices: | Drug price trends for CEFACLOR |
What excipients (inactive ingredients) are in CEFACLOR? | CEFACLOR excipients list |
DailyMed Link: | CEFACLOR at DailyMed |
Recent Clinical Trials for CEFACLOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundacion Clinic per a la Recerca Biomédica | Phase 4 |
James Graham Brown Cancer Center | Early Phase 1 |
Julio Ramirez | Early Phase 1 |
Pharmacology for CEFACLOR
Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFACLOR
Anatomical Therapeutic Chemical (ATC) Classes for CEFACLOR
US Patents and Regulatory Information for CEFACLOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ranbaxy | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064164-001 | Oct 2, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ranbaxy Labs Ltd | RANICLOR | cefaclor | TABLET, CHEWABLE;ORAL | 065092-002 | Dec 22, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dava Pharms Inc | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064115-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs Inc | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064206-001 | Feb 18, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ranbaxy | CEFACLOR | cefaclor | CAPSULE;ORAL | 064156-001 | Aug 28, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.